Fresenius Kabi makes Samarind RMS its first choice
Samarind RMS has been chosen by Fresenius Kabi to support its global regulatory tracking.
Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in its most important countries of Latin America and Asia Pacific. Within I.V. generic drugs, Fresenius Kabi counts among the leading suppliers, in particular in the U.S. market.
Fresenius-Kabi has a large portfolio of products and needed a cohesive, robust software application to manage its global licence portfolio. Aside from identifying Samarind RMS as being a fit for purpose application, another key factor in their selection was Samarind's customer focused approach and willingness to work as a partner to accommodate Fresenius-Kabi's needs.
Dr. Dr. Michel Mikhail, Senior Vice President of Corporate Regulatory Affairs at Fresenius Kabi Deutschland GmbH commented, "With a large portfolio of products we needed a modern and flexible software system to cope with all of the variables and the worldwide diversified portfolio. We are very impressed with Samarind's openness to our needs and our worldwide portfolio, their willingness to work in partnership with Fresenius Kabi Deutschland GmbH global regulatory and IT teams to ensure our needs are met precisely."
Samarind's Software Director, Miranda Pothiawala comments "We're enormously proud to have been Fresenius-Kabi's first choice to supply their global regulatory tracking system. Samarind RMS will support users in over one hundred countries from a single server installation, which demonstrates Samarind RMS's credentials as a genuine world-class software product."
"This latest success gives our whole team great confidence to push Samarind further ahead in producing world-class regulatory affairs software and we look forward to building a long lasting and successful partnership with Fresenius-Kabi."
With integrated submissions tracking, document management and eCTD publishing tools, Samarind RMS is being recognised more and more as a class-leading product. For further information please visit our website: www.samarindrms.com or alternatively contact Phil Turner on +44 (0) 1244 288281.